Table 1.
Patient no. | Age, y | MDS subtype | Karyotype | Hemoglobin, g/dL | Clonal cells (FISH), % | Actin disruption, % | GlyA (day 14), % |
MDS 1 | 60 | RCMD | −7 | 6 | 18.53 | 91.7 | 80.67 |
MDS2 | 67 | RA | −7 | 8 | 2.96 | 77.7 | 98.7 |
MDS 3 | 70 | RAEB | −7 | 6.6 | 66.67 | 93 | 2.7 |
MDS 4 | 83 | RA | −7 | 7 | 12.26 | 50.2 | 90 |
MDS 5 | 67 | RCMD | −7 | 6.7 | 10.15 | 24.9 | 97.9 |
MDS 6 | 77 | RCMD | Complex −7 | 11.4 | 10 | 82.14 | 65.6 |
MDS 7 | 63 | RCMD | Complex −7 | 12.7 | 35 | 52.8 | 55.5 |
MDS 8 | 75 | RCMD | Complex −7 | 9.8 | 5.5 | 77.7 | 56.7 |
MDS 9 | 84 | RAEB | Complex −7 | 7.6 | 6 | 50.37 | 59.9 |
MDS 10 | 74 | RCMD | Complex −7 | 12 | 7.75 | 79.6 | 51 |
RAEB, RA with excess blasts; RCMD, refractory cytopenias with multilineage dysplasia.